Tirzepatide is a novel peptide compound developed for metabolic research applications. This GLP-1 and GIP receptor agonist has shown promising results in weight management studies when combined with proper diet and exercise.
Our facility produces pharmaceutical-grade tirzepatide with strict quality control measures. The product is supplied as a lyophilized powder in sterile vials, ensuring optimal stability and purity for research purposes.
The compound demonstrates significant effects on body weight reduction and metabolic parameters in clinical studies. Researchers have observed average weight loss of 15-20% in trial participants over extended treatment periods.
For laboratory use only. This product is not intended for human consumption or diagnostic use. Proper safety protocols should be followed when handling research compounds.
Storage recommendations include maintaining the product at controlled temperatures between 2-8°C for short-term use or -20°C for long-term preservation. The lyophilized form remains stable for extended periods when stored properly.
Our competitive tirzepatide prices make this innovative compound accessible for research institutions and pharmaceutical developers. Bulk quantities available for large-scale studies and formulation development.